The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Malaria antifolate resistance with contrasting Plasmodium falciparum dihydrofolate reductase (DHFR) polymorphisms in humans and Anopheles mosquitoes.
Sungano Mharakurwa; Taida Kumwenda; Mtawa A P Mkulama; Mulenga Musapa; Sandra Chishimba; Clive J Shiff; David J Sullivan; Philip E Thuma; Kun Liu; Peter Agre (Profiled Authors: Clive Shiff; Kun Liu; David Sullivan; Sungano Mharakurwa; Peter Agre)
The Malaria Institute at Macha, Choma, Zambia.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(46):18796-801.
Surveillance for drug-resistant parasites in human blood is a major effort in malaria control. Here we report contrasting antifolate resistance polymorphisms in Plasmodium falciparum when parasites in human blood were compared with parasites in Anopheles vector mosquitoes from sleeping huts in rural Zambia. DNA encoding P. falciparum dihydrofolate reductase (EC 184.108.40.206) was amplified by PCR with allele-specific restriction enzyme digestions. Markedly prevalent pyrimethamine-resistant mutants were evident in human P. falciparum infections--S108N (>90%), with N51I, C59R, and 108N+51I+59R triple mutants (30-80%). This resistance level may be from selection pressure due to decades of sulfadoxine/pyrimethamine use in the region. In contrast, cycloguanil-resistant mutants were detected in very low frequency in parasites from human blood samples-S108T (13%), with A16V and 108T+16V double mutants (∼4%). Surprisingly, pyrimethamine-resistant mutants were of very low prevalence (2-12%) in the midguts of Anopheles arabiensis vector mosquitoes, but cycloguanil-resistant mutants were highly prevalent-S108T (90%), with A16V and the 108T+16V double mutant (49-57%). Structural analysis of the dihydrofolate reductase by in silico modeling revealed a key difference in the enzyme within the NADPH binding pocket, predicting the S108N enzyme to have reduced stability but the S108T enzyme to have increased stability. We conclude that P. falciparum can bear highly host-specific drug-resistant polymorphisms, most likely reflecting different selective pressures found in humans and mosquitoes. Thus, it may be useful to sample both human and mosquito vector infections to accurately ascertain the epidemiological status of drug-resistant alleles.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Fabián Méndez; Sócrates Herrera; Bermans Murrain; Andrés Gutiérrez; Luz A Moreno; María Manzano; Alvaro Muñoz; Christopher V PloweThe American journal of tropical medicine and hygiene 2007;77(3):438-43.
Mtawa A P Mkulama; Sandra Chishimba; Jay Sikalima; Petrica Rouse; Philip E Thuma; Sungano MharakurwaMalaria journal 2008;7():87.
Joseph F Cortese; Alejandro Caraballo; Carmen E Contreras; Christopher V PloweThe Journal of infectious diseases 2002;186(7):999-1006.
Appears in this Publication
Author of this Publication